CGD

Clinical trials for CGD explained in plain language.

Never miss a new study

Get alerted when new CGD trials appear

Sign up with your email to follow new studies for CGD, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Not yet finished but already full! 1

Can a new antibody make stem cell transplants safer for CGD patients?

Cure Ongoing

Chronic granulomatous disease (CGD) is a rare immune disorder that causes severe infections, and the only cure is a stem cell transplant. Transplants from unrelated donors can be risky, so researchers are testing whether adding the drug JSP191 before the transplant helps the dono…

Matched conditions: CGD

Early phase 1 • Sponsor: National Institute of Allergy and Infectious Diseases (NIAID) • Aim: Cure

Last updated Aug 29, 2026 00:00 UTC

CGD

Get alerted when new CGD trials appear

Can a new antibody make stem cell transplants safer for CGD patients?